Companies push ahead on cannabis-infused gummy plans despite hazy regulations

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 92%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Companies push ahead on cannabis-infused gummy plans despite hazy regulations GlobeBusiness

. The rules laid out so far are aimed at keeping the new pot products out of the hands of kids and stipulate they can’t be seen as “appealing to young persons” – but Health Canada has yet to provide additional details on exactly what crosses the line.

The earliest new goods can be sold legally will be mid-December, due to the required 60-day notice companies must provide to Health Canada of their intent to sell them. In the U.S., where edibles are already available in several states where recreational pot is legalized, gummies are more popular than ever, according to BDS Analytics.

The risks to children of such products were outlined in recent research by the Canadian Paediatric Society, which found that a “significant number of young children” required medical care after ingesting cannabis in the months surrounding legalization last October.The preliminary research found 16 reported cases involving recreational pot between September and December 2018.

“It will be a significant impact,” said Malkani, noting that gummies are expected to account for roughly eight or nine per cent of edibles in Quebec.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 5. in İD

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pharmaceutical companies file constitutional challenge to Canada’s new drug price regulationsCompanies have said lower prices will make international drug manufacturers less likely to bring new medications to Canada.
Sumber: globeandmail - 🏆 5. / 92 Baca lebih lajut »